NRAS and metastatic melanoma: In metastatic melanoma patients, ctDNA detection promotes the identification of typical mutations (i.e., BRAF and Neuroblastoma RAS Viral Oncogene Homolog (NRAS)) and epigenetic markers such as methylated DNA [47,87].